scholarly journals The impact of functional food on the prevention and treatment of respiratory diseases

2020 ◽  
Vol 33 (4) ◽  
pp. 228-232
Author(s):  
Gabriela Widelska ◽  
Kamila Kasprzak-Drozd ◽  
Karolina Wojtunik-Kulesza ◽  
Anna Krajewska ◽  
Anna Oniszczuk
Keyword(s):  
Respiratory Tract ◽  
Functional Food ◽  
Causes Of Death ◽  
Chronic Obstructive ◽  
Respiratory Tract Diseases ◽  
Chronic Obstructive Pulmonary Disorder ◽  
Prevention And Treatment ◽  
Pulmonary Disorder ◽  
Ancient Times ◽  
The Impact

Abstract Globally, diseases of the lung are one of the main causes of death, and conventional therapies are often ineffective in dealing with this serious medical and sociological problem. Since ancient times, medicinal plants have been used in the treatment of respiratory tract diseases. Such plants show antitussive, muscle relaxing, bronchi dilation or cillary movement effects. Their usefulness has been confirmed by modern and current research. A medicinal plant that is also a functional food can open new areas in the prevention and treatment of respiratory tract diseases. In this review, information about the influence of functional food on preventing and treating asthma, chronic obstructive pulmonary disorder (COPD) and high-altitude sickness are presented.

Casing Design for an Oxygen Concentrator

1999 ◽  
Author(s):  
Stephanie H. Swindle ◽  
Beth A. Todd ◽  
James F. Cuttino
Keyword(s):  
Quality Of Life ◽  
Structural Integrity ◽  
Chronic Obstructive ◽  
Gas Mixture ◽  
Improve Quality ◽  
Chronic Obstructive Pulmonary Disorder ◽  
Element Analysis ◽  
Pulmonary Disorder ◽  
Oxygen Concentrator

Abstract Human bodies depend on a steady flow of oxygen for the heart and lungs. When a person has Chronic Obstructive Pulmonary Disorder (COPD), a device called an oxygen concentrator can be used to improve quality of life. An oxygen concentrator is an electrically powered device that takes in room air and converts it to an oxygen rich gas mixture suitable for breathing. Although a few models are battery powered, oxygen concentrators are not easily portable because they are bulky and weigh between 25–50 lbs. In this study, components were identified for re design to reduce the overall weight of the device. For instance, the concentrator casing was identified as its heaviest component. Using finite element analysis, changes in wall thickness and dimensions can be investigated to reduce weight while maintaining structural integrity. By reducing the weight of the casing, the oxygen concentrator will be easier to transport.

DIETARY ASSESSMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE PATIENTS VISITING TERTIARY CARE HOSPITAL OF LAHORE

2020 ◽  
pp. 5-10
Author(s):  
OJS Admin
Keyword(s):  
Chronic Obstructive Pulmonary Disease ◽  
Pulmonary Disease ◽  
Dietary Assessment ◽  
Tertiary Care ◽  
Health Concern ◽  
Chronic Obstructive ◽  
Care Hospital ◽  
Chronic Obstructive Pulmonary Disorder ◽  
Obstructive Pulmonary Disease ◽  
Pulmonary Disorder

Chronic obstructive pulmonary disorder (COPD) is an aggravating and major health concern throughout the world. It is estimated that in upcoming years chronic obstructive pulmonary disease will be rankedas third common reason of mortality and fifth common cause of disablement worldwide.

scholarly journals Comprehensive care programmes in chronic obstructive pulmonary disease: a systematic review and meta-analysis of randomized controlled trials and real-world studies

2021 ◽  
Author(s):  
Daniel Yoo ◽  
Mengqi Gong ◽  
Lei Meng ◽  
Cheuk Wai Wong ◽  
Guangping Li ◽  
...  
Keyword(s):  
Home Care ◽  
Meta Analysis ◽  
Comprehensive Care ◽  
Self Management ◽  
Chronic Obstructive ◽  
Chronic Obstructive Pulmonary Disorder ◽  
Obstructive Pulmonary Disease ◽  
Structured Care ◽  
Pulmonary Disorder ◽  
Medication Reviews

Background: Different comprehensive care programmes (CCPs) have been developed for patients with chronic obstructive pulmonary disorder (COPD), but data regarding their effectiveness have been controversial. PubMed and Embase were searched to 1st June 2017 for articles that investigated the effects of the different types of CCPs on hospitalization or mortality rates in COPD. Results: A total of 67 studies including 3472633 patients (mean age: 76.1+/-12.7 years old; 41% male) were analyzed. CCPs reduced all-cause hospitalizations (hazard ratio [HR]: 0.70, 95% confidence interval [CI]: 0.63-0.79; P<0.001; I2:96%) and mortality (HR: 0.69, 95% CI: 0.573-0.83; P<0.001; I2:75%). Subgroup analyses for different CCP types were performed. Hospitalizations were reduced by pharmacist-led medication reviews (HR: 0.54; 95% CI: 0.37-0.78; P=0.001; I2:49%), structured care programmes (HR: 0.76; 95% CI: 0.66-0.87; P<0.0001; I2:88%) and self-management programmes (HR: 0.79; 95% CI: 0.64-0.99; P<0.05; I2:78%), but not continuity of care programmes (HR: 0.70; 95% CI: 0.36-1.36; P=0.29; I2:100%), early support discharge or home care packages (HR: 0.97; 95% CI: 0.91-1.04; P=0.37; I2:0%) or telemonitoring (HR: 0.61; 95% CI: 0.32-1.18; P=0.14; I2:94%). Mortality was reduced by early support discharge or home care packages (HR: 0.49; 95% CI: 0.30-0.80; P<0.01; I2:72%), structured care programmes (HR: 0.69; 95% CI: 0.53-0.90; P<0.01; I2:61%) and telemonitoring (HR: 0.52; 95% CI: 0.31-0.89; P<0.05; I2:0%), but not self-management programmes (HR: 0.79; 95% CI: 0.64-0.99; P<0.05; I2:78%). Conclusions: Comprehensive care programmes reduce hospitalization and mortality in COPD patients.

scholarly journals Role of Diet in Chronic Obstructive Pulmonary Disease Prevention and Treatment

Nutrients ◽  
2019 ◽  
Vol 11 (6) ◽  
pp. 1357 ◽  
Author(s):  
Egeria Scoditti ◽  
Marika Massaro ◽  
Sergio Garbarino ◽  
Domenico Maurizio Toraldo
Keyword(s):  
Chronic Obstructive Pulmonary Disease ◽  
Lung Function ◽  
Pulmonary Disease ◽  
Dietary Patterns ◽  
Scientific Evidence ◽  
Chronic Obstructive ◽  
Lung Function Decline ◽  
Obstructive Pulmonary Disease ◽  
Prevention And Treatment ◽  
The Impact

Chronic obstructive pulmonary disease is one of the leading causes of morbidity and mortality worldwide and a growing healthcare problem. Identification of modifiable risk factors for prevention and treatment of COPD is urgent, and the scientific community has begun to pay close attention to diet as an integral part of COPD management, from prevention to treatment. This review summarizes the evidence from observational and clinical studies regarding the impact of nutrients and dietary patterns on lung function and COPD development, progression, and outcomes, with highlights on potential mechanisms of action. Several dietary options can be considered in terms of COPD prevention and/or progression. Although definitive data are lacking, the available scientific evidence indicates that some foods and nutrients, especially those nutraceuticals endowed with antioxidant and anti-inflammatory properties and when consumed in combinations in the form of balanced dietary patterns, are associated with better pulmonary function, less lung function decline, and reduced risk of COPD. Knowledge of dietary influences on COPD may provide health professionals with an evidence-based lifestyle approach to better counsel patients toward improved pulmonary health.

scholarly journals The Impact of Warfarin on Patients with End Stage Renal Disease

2014 ◽  
Vol 2014 ◽  
pp. 1-4
Author(s):  
Anahita Dua ◽  
Sapan S. Desai ◽  
Harvey J. Woehlck ◽  
Cheong J. Lee
Keyword(s):  
Renal Disease ◽  
Hospital Mortality ◽  
End Stage Renal Disease ◽  
Hospital Charges ◽  
Care Utilization ◽  
Chronic Obstructive ◽  
Chronic Obstructive Pulmonary Disorder ◽  
Stage Renal Disease ◽  
End Stage ◽  
The Impact

Introduction. A deficiency in vitamin K through the utilization of warfarin may result in increased vascular calcification and complications. This study aimed to determine the impact of warfarin administration on patients with end stage renal disease (ESRD) in a large, national sample. Methods. A retrospective analysis using the 2005–2010 National Inpatient Sample (NIS), a part of the Health Care Utilization Project (HCUP), was completed using ICD-9 diagnosis codes to capture patients with ESRD prescribed and not prescribed warfarin. Statistical analysis was through ANOVA and chi-squared testing. Results. From 2005–2010, 927,814 patients with ESRD were identified nationally. 3.5% (32,737) were prescribed warfarin. Patients prescribed warfarin had an average age of 64 years and 51% were male. For every comorbid condition (amputation, congestive heart failure, chronic obstructive pulmonary disorder, cerebrovascular accident, diabetes, hypertension, myocardial infarction, peripheral vascular diasese, and valvular disease) patients prescribed Warfarin had significantly higher rates of disease as compared to their nonwarfarin ESRD counterparts. ESRD patients prescribed warfarin had significantly shorter length of stay but increased hospital charges. They were more likely to be discharged to home and had significantly decreased in-hospital mortality. Conclusion. Patients with ESRD taking warfarin are more likely to have comorbidities and/or complications but have a decreased LOS and in-hospital mortality compared to their ESRD counterparts not administered warfarin.

Sign in / Sign up

Export Citation Format

Share Document